Resbiotic, Inc. Raises $3M Seed Round And Announces Leadership Team
04/29/21, 6:26 PM
Location
birminghamMoney raised
$3 million
Round Type
seed
University of Alabama at Birmingham's biotech startup Resbiotic, Inc. today announced a $3M seed round to support the development and commercialization of groundbreaking probiotic formulations for lung health. The round was funded from a private equity syndicate led by Timberline Holdings.
Company Info
Company
Res Biotic
Location
birmingham, alabama, united states
Additional Info
After years of research, we can now modulate how the microbiota influence lung diseases. The commercialization of this work from University of Alabama at Birmingham, led by ResBiotic founder and Chief Scientific Officer C. Vivek Lal MD FAAP, has the potential to be life changing for respiratory disease patients. ResBiotic is developing first-in-class products that alleviate the neutrophilic inflammation associated with dysbiosis to improve respiratory health.